Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Metric	MRKMerck & Co.	AZNAstraZeneca PLC	NVSNovartis AG
Snapshot
Price	$150.88	$161.75	$161.74
Market cap	$319.99B	$284.73B	$261.56B
Valuation
P/E	41.6x	24.9x	22.4x
Forward P/E	59.4x	18.6x	20.5x
Growth
Revenue growth	2.9%	9.9%	5.8%
EPS growth	-48.3%	33.7%	9.3%
Profitability
Net margin	13.6%	17.2%	24.1%
ROE	17.9%	22.3%	31.7%
Balance sheet & cash
Debt / equity	0.94x	0.61x	0.77x
Free cash flow yield	2.9%	3.1%	4.2%
Dividend yield	3.0%	1.7%	2.9%
Verdict
Investment rating	Weak· 35	Favorable· 68	Favorable· 67

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

Year	MRKtoday $151	AZNtoday $162	NVStoday $162
2027	$115.42 – $169.29+12% CAGR	$162.21 – $237.90+47% CAGR	$132.55 – $194.41+20% CAGR
2028	$117.73 – $172.67+7% CAGR	$216.89 – $318.10+40% CAGR	$144.84 – $212.43+15% CAGR
2029	$120.09 – $176.13+5% CAGR	$290.00 – $425.33+38% CAGR	$158.26 – $232.12+13% CAGR
2030	$122.49 – $179.65+4% CAGR	$387.76 – $568.71+37% CAGR	$172.93 – $253.64+12% CAGR
2031	$124.94 – $183.24+4% CAGR	$518.47 – $760.43+36% CAGR	$188.97 – $277.15+11% CAGR
5-yr CAGR	-3.7% – 4.0%	26.2% – 36.3%	3.2% – 11.4%